Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
Background: The combination of sofosbuvir (SOF), ribavirin (RBV) and peg-interferon-alfa-2a (peg-IFN-alfa-2a) as well as the combination of SOF and RBV for the treatment of patients infected with hepatitis c virus (HCV) has improved rates of sustained virological response (SVR) considerably in recen...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
04 August 2015
|
| In: |
BMC gastroenterology
Year: 2015, Volume: 15 |
| ISSN: | 1471-230X |
| DOI: | 10.1186/s12876-015-0328-9 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12876-015-0328-9 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12876-015-0328-9 |
| Author Notes: | Niels Steinebrunner, Martin F. Sprinzl, Tim Zimmermann, Marcus A. Wörns, Thomas Zimmerer, Peter R. Galle, Wolfgang Stremmel, Christoph Eisenbach, Kerstin Stein, Christoph Antoni, Jörn M. Schattenberg and Anita Pathil |
Search Result 1
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
BioMed Central 2015
Article (Journal)
Book/Monograph
Online Resource